ADA and ADK expression was upregulated in peritumoral tissues derived from patients with epilepsy compared to those without epilepsy [57,58], whereas the number of ADA-positive or ADK-positive cells in tumor tissues was similar between glioma patients with and without epilepsy [58]. The gene discussed is ADA; the disease is central nervous system cancer.